Answers are grounded in this paper and cite their sources.
Preclinical evaluation demonstrates magnetically controlled dual-target drug release and anchoring in porcine intestines, suggesting a viable platform for multifocal gastrointestinal therapy.
Gastrointestinal (GI) drug delivery remains challenging because sustained constant-rate infusion and positional stability are difficult to achieve simultaneously. Conventional magnetic capsules often rely on burst-type or nonlinear release mechanisms. To address these limitations, a magnetically controlled dual-target constant-rate drug delivery capsule system (M-DCDC) is presented. The system enables highly linear and quantitatively adjustable drug infusion through specialized screw–piston transmission. This mechanism establishes a direct relationship between the magnetic rotation frequency and the delivery rate, achieving a maximum flow rate of 0.1 mL/s with predictable dosage control. Sequential dual-target delivery is achieved through functional decoupling. By reversing the direction of the magnetic field, two independent reservoirs, each with a volume of 0.6 mL, can be selectively actuated at separate target sites. To resist intestinal peristalsis, a self-locking mechanical anchoring module is integrated to maintain positional stability without continuous power consumption. Analytical modeling, finite element analysis (FEA), benchtop tests, and ex vivo experiments using porcine intestines demonstrate that M-DCDC can withstand a peristaltic force of 0.32 N while achieving localized staining. By combining stable anchoring with decoupled constant-rate infusion, the proposed system offers an effective engineering approach for targeted treatment of multifocal GI diseases.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: